Association of Blood Pressure-Related Increase in Vascular Stiffness on Other Measures of Target Organ Damage in Youth.
adiposity
blood pressure
pediatrics
pulse wave analysis
risk factors
Journal
Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
pubmed:
29
6
2022
medline:
13
8
2022
entrez:
28
6
2022
Statut:
ppublish
Résumé
Hypertension-related increased arterial stiffness predicts development of target organ damage (TOD) and cardiovascular disease. We hypothesized that blood pressure (BP)-related increased arterial stiffness is present in youth with elevated BP and is associated with TOD. Participants were stratified by systolic BP into low- (systolic BP <75th percentile, n=155), mid- (systolic BP ≥80th and <90th percentile, n=88), and high-risk BP categories (≥90th percentile, n=139), based on age-, sex- and height-specific pediatric BP cut points. Clinic BP, 24-hour ambulatory BP monitoring, anthropometrics, and laboratory data were obtained. Arterial stiffness measures included carotid-femoral pulse wave velocity and aortic stiffness. Left ventricular mass index, left ventricular systolic and diastolic function, and urine albumin/creatinine were collected. ANOVA with Bonferroni correction was used to evaluate differences in cardiovascular risk factors, pulse wave velocity, and cardiac function across groups. General linear models were used to examine factors associated with arterial stiffness and to determine whether arterial stiffness is associated with TOD after accounting for BP. Pulse wave velocity increased across groups. Aortic distensibility, distensibility coefficient, and compliance were greater in low than in the mid or high group. Significant determinants of arterial stiffness were sex, age, adiposity, BP, and LDL (low-density lipoprotein) cholesterol. Pulse wave velocity and aortic compliance were significantly associated with TOD (systolic and diastolic cardiac function and urine albumin/creatinine ratio) after controlling for BP. Higher arterial stiffness is associated with elevated BP and TOD in youth emphasizing the need for primary prevention of cardiovascular disease.
Sections du résumé
BACKGROUND
Hypertension-related increased arterial stiffness predicts development of target organ damage (TOD) and cardiovascular disease. We hypothesized that blood pressure (BP)-related increased arterial stiffness is present in youth with elevated BP and is associated with TOD.
METHODS
Participants were stratified by systolic BP into low- (systolic BP <75th percentile, n=155), mid- (systolic BP ≥80th and <90th percentile, n=88), and high-risk BP categories (≥90th percentile, n=139), based on age-, sex- and height-specific pediatric BP cut points. Clinic BP, 24-hour ambulatory BP monitoring, anthropometrics, and laboratory data were obtained. Arterial stiffness measures included carotid-femoral pulse wave velocity and aortic stiffness. Left ventricular mass index, left ventricular systolic and diastolic function, and urine albumin/creatinine were collected. ANOVA with Bonferroni correction was used to evaluate differences in cardiovascular risk factors, pulse wave velocity, and cardiac function across groups. General linear models were used to examine factors associated with arterial stiffness and to determine whether arterial stiffness is associated with TOD after accounting for BP.
RESULTS
Pulse wave velocity increased across groups. Aortic distensibility, distensibility coefficient, and compliance were greater in low than in the mid or high group. Significant determinants of arterial stiffness were sex, age, adiposity, BP, and LDL (low-density lipoprotein) cholesterol. Pulse wave velocity and aortic compliance were significantly associated with TOD (systolic and diastolic cardiac function and urine albumin/creatinine ratio) after controlling for BP.
CONCLUSIONS
Higher arterial stiffness is associated with elevated BP and TOD in youth emphasizing the need for primary prevention of cardiovascular disease.
Identifiants
pubmed: 35762327
doi: 10.1161/HYPERTENSIONAHA.121.18765
pmc: PMC9378473
mid: NIHMS1815605
doi:
Substances chimiques
Albumins
0
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2042-2050Subventions
Organisme : American Heart Association-American Stroke Association
ID : 15SFRN23680000
Pays : United States
Références
J Hypertens. 2002 Oct;20(10):1995-2007
pubmed: 12359978
Eur Heart J. 2008 Feb;29(4):472-9
pubmed: 18096569
Curr Hypertens Rev. 2018;14(2):137-153
pubmed: 29651954
J Am Coll Cardiol. 1995 Apr;25(5):1056-62
pubmed: 7897116
Hypertension. 2013 Nov;62(5):934-41
pubmed: 24001897
Ren Fail. 2009;31(2):140-3
pubmed: 19212911
J Pediatr. 2011 May;158(5):715-21
pubmed: 21300369
J Pediatr. 2007 Mar;150(3):247-51
pubmed: 17307539
Kidney Int Suppl (2011). 2013 Jan;3(1):19-62
pubmed: 25018975
MMWR Morb Mortal Wkly Rep. 2018 Jul 13;67(27):758-762
pubmed: 30001558
Cardiol Young. 2018 Mar;28(3):403-408
pubmed: 29223189
Clin Chem. 2019 Jan;65(1):108-118
pubmed: 30459170
J Hypertens. 2010 Aug;28(8):1692-8
pubmed: 20647860
Clin Cardiol. 2008 Jul;31(7):304-9
pubmed: 17957740
J Am Soc Hypertens. 2014 Jun;8(6):414-21
pubmed: 24952654
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
pubmed: 15286277
J Rheumatol. 2007 Jun;34(6):1345-52
pubmed: 17477468
J Clin Hypertens (Greenwich). 2011 May;13(5):332-42
pubmed: 21545394
J Hypertens. 2001 Mar;19(3):381-7
pubmed: 11288807
Clin Exp Hypertens. 2010 Jan;32(2):84-9
pubmed: 20374190
J Pediatr. 2020 Mar;218:98-105.e3
pubmed: 31810627
Pediatr Int. 2018 Feb;60(2):127-135
pubmed: 29230906
Pediatrics. 2017 Sep;140(3):
pubmed: 28827377
Rev Saude Publica. 2015;49:23
pubmed: 25902563
Atherosclerosis. 2011 Nov;219(1):194-9
pubmed: 21840525
Adv Data. 2000 Jun 8;(314):1-27
pubmed: 11183293
Hypertension. 2018 Oct;72(4):955-961
pubmed: 30354718
Hypertension. 2018 Sep;72(3):625-631
pubmed: 29987102
Curr Cardiol Rev. 2009 May;5(2):133-48
pubmed: 20436854
J Clin Hypertens (Greenwich). 2017 Mar;19(3):221-226
pubmed: 27511880
Chonnam Med J. 2016 May;52(2):101-6
pubmed: 27231673
Physiol Res. 2008;57(2):303-306
pubmed: 18570537
J Am Soc Echocardiogr. 2018 Jan;31(1):99-104
pubmed: 29174337
Hypertension. 2015 Sep;66(3):698-722
pubmed: 26160955
Hypertension. 2009 Nov;54(5):919-50
pubmed: 19729599
Hypertension. 2018 Jun;71(6):e13-e115
pubmed: 29133356
Hypertension. 2012 Aug;60(2):550-5
pubmed: 22733475
J Am Coll Cardiol. 2020 Jun 16;75(23):2921-2930
pubmed: 32527401
PLoS One. 2019 Dec 19;14(12):e0226709
pubmed: 31856244
J Hypertens. 2015 Jan;33(1):88-95
pubmed: 25269016
J Dev Orig Health Dis. 2014 Aug;5(4):307-13
pubmed: 24965137
Hypertension. 2019 Sep;74(3):590-596
pubmed: 31327264
Obes Res Clin Pract. 2013 May-Jun;7(3):e211-7
pubmed: 23697590
Hypertension. 2009 Dec;54(6):1328-36
pubmed: 19884567
J Am Soc Echocardiogr. 2004 Oct;17(10):1086-119
pubmed: 15452478
Eur J Pediatr. 2006 Sep;165(9):625-9
pubmed: 16636815
Hypertension. 2019 Jan;73(1):153-161
pubmed: 30571553
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Am J Hypertens. 2002 May;15(5):426-44
pubmed: 12022246
Metab Syndr Relat Disord. 2018 Nov;16(9):490-496
pubmed: 30183523
Circulation. 1992 Dec;86(6):1909-18
pubmed: 1451262
Clin Physiol Biochem. 1983;1(1):36-56
pubmed: 6679476
Am J Cardiol. 1986 Feb 15;57(6):450-8
pubmed: 2936235
Circulation. 2002 Mar 12;105(10):1202-7
pubmed: 11889014
J Am Heart Assoc. 2019 Jul 2;8(13):e010150
pubmed: 31213111
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
Circulation. 2010 Feb 2;121(4):505-11
pubmed: 20083680
J Hypertens. 2019 Mar;37(3):563-571
pubmed: 30234784